The key facts
- Starting in 2027, two new anti-cancer drugs will be available under mandatory health insurance
- The drugs are intended for the treatment of skin melanoma and gastrointestinal tract tumors
- Golikova called them unique Russian products with no world analogues
Two new anti-cancer drugs will be included in the mandatory health insurance program
Next year, Russians will be able to receive drugs for the treatment of skin melanoma and gastrointestinal tract tumors free of charge under the mandatory medical insurance program. This was announced by Deputy Prime Minister Tatyana Golikova at a session of the IV International Forum of Nature-Like Technologies held at the National Research Center 'Kurchatov Institute', her words were reported by TASS.
How the drugs work
According to Golikova, these are individualized drugs that teach the immune system to recognize tumor cells. 'These are unique Russian products with no world analogues,' the deputy prime minister was quoted by Gazeta.Ru.
Context
The announcement about including the drugs in the mandatory health insurance program came against the backdrop of other recent oncology news. In particular, scientists from Johns Hopkins University concluded that triptolide — a natural compound from a plant used in traditional Chinese medicine — may help tumor cells overcome resistance to treatment and increase the effectiveness of some anti-cancer drugs. In addition, a doctor previously explained whether deodorants with aluminum salts can increase the risk of breast cancer.
